bromocriptine has been researched along with methysergide in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (62.96) | 18.7374 |
1990's | 7 (25.93) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (7.41) | 24.3611 |
2020's | 1 (3.70) | 2.80 |
Authors | Studies |
---|---|
Hamblin, MW; Jose, PA; Metcalf, MA; Monsma, FJ; Shen, Y; Sibley, DR | 1 |
Druck, T; Hamblin, MW; Huebner, K; Khan, N; Kohen, R; Lachowicz, JE; Meltzer, HY; Metcalf, MA; Roth, BL; Sibley, DR | 1 |
Boess, FG; Monsma, FJ; Sleight, AJ | 1 |
Jadhav, A; Kerns, E; Nguyen, K; Shah, P; Sun, H; Xu, X; Yan, Z; Yu, KR | 1 |
Kabir, M; Kerns, E; Nguyen, K; Shah, P; Sun, H; Wang, Y; Xu, X; Yu, KR | 1 |
Kabir, M; Kerns, E; Neyra, J; Nguyen, K; Nguyễn, ÐT; Shah, P; Siramshetty, VB; Southall, N; Williams, J; Xu, X; Yu, KR | 1 |
Asper, H; Bürki, HR; Ruch, W; Züger, PE | 1 |
Castegnaro, E; Pontiroli, AE; Pozza, G; Vettaro, MP; Viberti, GC | 1 |
Berde, B | 1 |
de Andrés, C; Giménez-Roldán, S; Salinero, E | 1 |
Caldara, R; Curtarelli, G; Ferrari, C; Rampini, P; Romussi, M; Telloli, P; Zaatar, S | 1 |
Marchlewska-Koj, A | 1 |
Bertazzoni, A; Caldara, R; Crosignani, PG; Ferrari, C; Mattei, A; Polloni, G; Rampini, P; Romussi, M; Telloli, P | 1 |
Flores, CM; Hornby, PJ; Hulihan-Giblin, BA; Kellar, KJ; Lumpkin, MD | 1 |
Poddar, MK; Ray, SK | 1 |
Lechevalier, B; Viader, F | 1 |
Bloom, FE; Koob, GF; Mitchiner, M; Weiss, F | 1 |
Chiodini, PG; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Verde, GG | 1 |
Bános, C; Földes, J; Gara, A; Székely, JI; Török, K; Váradi, A; Vargha, P | 1 |
Flechter, S; Graff, E; Oberman, Z; Rabey, JM; Vardi, J | 1 |
Sahn, SA | 1 |
Kanto, J | 1 |
Ruckebusch, Y | 1 |
Norman, RL; Pavasuthipaisit, K; Spies, HG | 1 |
Horowski, R | 1 |
Alberetto, M; De Castro e Silva, E; De Pasqua, A; Girardi, AM; Pellicciotta, G; Pontiroli, AE; Pozza, G | 1 |
Brownell, J; Clarenbach, P; Cramer, H; Del Pozo, E; Heredia, E; Spiegel, R | 1 |
4 review(s) available for bromocriptine and methysergide
Article | Year |
---|---|
Pharmacology of ergot alkaloids in clinical use.
Topics: Animals; Brain Diseases; Bromocriptine; Dihydroergotamine; Dihydroergotoxine; Dopamine Antagonists; Ergot Alkaloids; Ergotamine; Female; Humans; Methysergide; Migraine Disorders; Parkinson Disease; Pituitary Gland; Prolactin; Receptors, Adrenergic; Receptors, Dopamine; Uterus; Vasoconstriction | 1978 |
Medical treatment of pituitary adenomas: effects on tumor growth.
Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Dihydroergotoxine; Dopamine; Drug Administration Schedule; Ergolines; Growth Hormone; Levodopa; Lisuride; Metergoline; Methysergide; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1985 |
Immunologic diseases of the pleura.
Topics: Adult; Aged; Bromocriptine; Cardiac Surgical Procedures; Collagen Diseases; Dantrolene; Female; Granulomatosis with Polyangiitis; Heart Injuries; Humans; Immune System Diseases; Immunoblastic Lymphadenopathy; Lupus Erythematosus, Systemic; Male; Methotrexate; Methysergide; Middle Aged; Myocardial Infarction; Nitrofurantoin; Pacemaker, Artificial; Pleural Diseases; Pleural Effusion; Practolol; Procarbazine; Rheumatic Diseases; Sarcoidosis; Syndrome; Thoracic Injuries | 1985 |
Clinical pharmacokinetics of ergotamine, dihydroergotamine, ergotoxine, bromocriptine, methysergide, and lergotrile.
Topics: Absorption; Animals; Bromocriptine; Dihydroergotamine; Ergolines; Ergot Alkaloids; Ergotamine; Half-Life; Humans; Kinetics; Methysergide | 1983 |
4 trial(s) available for bromocriptine and methysergide
Article | Year |
---|---|
Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine.
Topics: Administration, Oral; Adolescent; Adult; Benserazide; Bromocriptine; Clinical Trials as Topic; Drug Interactions; Ergolines; Female; Humans; Hydrazines; Levodopa; Male; Metergoline; Methysergide; Middle Aged; Pituitary Gland; Pituitary Gland, Anterior; Prolactin; Secretory Rate; Stimulation, Chemical; Time Factors | 1977 |
Prolactin suppression by serotonin antagonists in man: further evidence for serotoninergic control of prolactin secretion.
Topics: Adolescent; Adult; Aged; Bromocriptine; Female; Humans; Male; Metergoline; Methysergide; Middle Aged; Pimozide; Prolactin; Serotonin Antagonists | 1978 |
Inhibition of prolactin release by serotonin antagonists in hyperprolactinemic subjects.
Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Male; Metergoline; Methysergide; Pituitary Diseases; Prolactin | 1978 |
Characterization of ergot and non-ergot serotonin antagonists by prolactin and growth hormone profiles during wakefulness and sleep.
Topics: Adult; Bromocriptine; Ergot Alkaloids; Female; Growth Hormone; Humans; Male; Methysergide; Pizotyline; Prolactin; Receptors, Dopamine; Serotonin Antagonists; Sleep Stages; Wakefulness | 1980 |
19 other study(ies) available for bromocriptine and methysergide
Article | Year |
---|---|
Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Cell Line; Cell Membrane; Cloning, Molecular; Cyclic AMP; Gene Expression; Kidney Tubules, Proximal; Lysergic Acid Diethylamide; Molecular Sequence Data; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Radioligand Assay; Rats; Receptors, Serotonin; Recombinant Proteins; Serotonin; Transfection | 1993 |
Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor.
Topics: Adenylyl Cyclases; Amino Acid Sequence; Animals; Antipsychotic Agents; Base Sequence; Brain Chemistry; Cell Line, Transformed; Chlorocebus aethiops; Chromosome Mapping; Chromosomes, Human, Pair 1; Cloning, Molecular; Clozapine; DNA, Complementary; Genes; Humans; Kinetics; Molecular Sequence Data; Open Reading Frames; Protein Conformation; Rats; Receptors, Serotonin; Recombinant Proteins; Sequence Alignment; Sequence Homology, Nucleic Acid; Serotonin Agents; Signal Transduction; Species Specificity | 1996 |
Identification of residues in transmembrane regions III and VI that contribute to the ligand binding site of the serotonin 5-HT6 receptor.
Topics: Adenylyl Cyclases; Amino Acid Substitution; Binding Sites; Binding, Competitive; Cell Line; Cyclic AMP; Humans; Ligands; Lysergic Acid Diethylamide; Mutagenesis, Site-Directed; Mutation; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists | 1998 |
Highly predictive and interpretable models for PAMPA permeability.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Humans; Models, Biological; Organic Chemicals; Regression Analysis; Support Vector Machine | 2017 |
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
Topics: Drug Discovery; Organic Chemicals; Pharmaceutical Preparations; Solubility | 2019 |
Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models.
Topics: Animals; Computer Simulation; Databases, Factual; Drug Discovery; High-Throughput Screening Assays; Liver; Machine Learning; Male; Microsomes, Liver; National Center for Advancing Translational Sciences (U.S.); Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Rats; Rats, Sprague-Dawley; Retrospective Studies; United States | 2020 |
Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF25--397, and 29--712: effects on the metabolism of the biogenic amines in the brain of the rat.
Topics: Animals; Biogenic Amines; Brain; Bromocriptine; Dihydroergotoxine; Dopamine; Ergolines; Lysergic Acid Diethylamide; Male; Methysergide; Nitriles; Pyridines; Rats; Receptors, Drug; Reserpine; Serotonin | 1978 |
[Therapy of progressive supranuclear paralysis. Effect of methysergide and bromocriptine on various psychoneurologic and motor functions].
Topics: Aged; Bromocriptine; Bulbar Palsy, Progressive; Demyelinating Diseases; Humans; Male; Methysergide; Motor Activity; Ophthalmoplegia; Syndrome | 1979 |
Evidence for the involvement of dopaminergic neurons in the pregnancy block effect.
Topics: Animals; Bromocriptine; Central Nervous System; Dopamine; Embryo Implantation; Female; Methysergide; Mice; Mice, Inbred CBA; Pheromones; Pimozide; Pregnancy; Prolactin; Serotonin | 1978 |
Partial characterization of a neurotransmitter pathway regulating the in vivo release of prolactin.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Bromocriptine; Haloperidol; Male; Mecamylamine; Methysergide; Morphine; Naltrexone; Narcotic Antagonists; Neurotransmitter Agents; Nicotine; Nicotinic Antagonists; Pituitary Gland; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Nicotinic; Receptors, Opioid; Receptors, Serotonin; Serotonin Antagonists; Tetrahydronaphthalenes | 1992 |
Interaction of central serotonin and dopamine in the regulation of carbaryl-induced tremor.
Topics: 5-Hydroxytryptophan; Acetylcholinesterase; Animals; Atropine; Behavior, Animal; Brain Chemistry; Bromocriptine; Carbaryl; Corpus Striatum; Dopamine; Haloperidol; Hydroxyindoleacetic Acid; Male; Methysergide; Physostigmine; Rats; Serotonin; Tremor | 1990 |
[Progressive supranuclear paralysis (Steele Richardson-Olszewski disease). After twenty-one years].
Topics: Bromocriptine; Humans; Methysergide; Parasympatholytics; Supranuclear Palsy, Progressive; Time Factors | 1990 |
Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide.
Topics: Alcohol Drinking; Animals; Bromocriptine; Conditioning, Operant; Dose-Response Relationship, Drug; Drinking; Ethanol; Male; Methysergide; Naloxone; Rats; Rats, Inbred Strains; Self Administration; Species Specificity | 1990 |
Effects of methysergide, bromocriptine and naloxone on prolactin, growth hormone and TSH release induced by D-Met2,Pro5-enkephalinamide in man.
Topics: Adult; Bromocriptine; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Enkephalin, Methionine; Growth Hormone; Humans; Male; Methysergide; Naloxone; Prolactin; Thyrotropin; Time Factors | 1986 |
Selective regional effect of various neuroactive drugs on bromocriptine concentration in the brain of rats.
Topics: Amantadine; Animals; Biperiden; Brain Chemistry; Bromocriptine; Carbidopa; Diazepam; Haloperidol; Levodopa; Methysergide; Naloxone; Rats | 1986 |
Enhancement of the cyclic motor activity of the ovine small intestine by lysergic acid derivatives. Mechanism and significance.
Topics: Action Potentials; Animals; Bromocriptine; Duodenum; Ergolines; Gastrointestinal Motility; Intestine, Small; Lysergic Acid; Methylergonovine; Methysergide; Periodicity; Pyloric Antrum; Serotonin; Serotonin Antagonists; Sheep; Vagotomy | 1984 |
Evidence that serotonin is involved in prolactin release by electrical stimulation of the medial basal hypothalamus in the rhesus monkey.
Topics: Animals; Bromocriptine; Electric Stimulation; Female; Hypothalamus; Hypothalamus, Middle; Macaca mulatta; Methysergide; Prolactin; Serotonin; Thyrotropin-Releasing Hormone | 1980 |
Some aspects of the dopaminergic action of ergot derivatives and their role in the treatment of migraine.
Topics: Animals; Behavior, Animal; Bromocriptine; Ergotamines; Female; Humans; Lisuride; Metergoline; Methysergide; Migraine Disorders; Neurons; Pituitary Gland; Prolactin; Rats; Receptors, Dopamine; Receptors, Serotonin; Serotonin Antagonists | 1982 |
Interaction of dopaminergic and antiserotoninergic drugs in the control of prolactin and LH release in normal women.
Topics: Adult; Bromocriptine; Dopamine; Drug Interactions; Female; Humans; Levodopa; Luteinizing Hormone; Metergoline; Methysergide; Prolactin; Receptors, Dopamine; Serotonin; Serotonin Antagonists | 1980 |